ZIOPHARM ONCOLOGY INC's ticker is ZIOP and the CUSIP is 98973P101. A total of 137 filers reported holding ZIOPHARM ONCOLOGY INC in Q3 2018. The put-call ratio across all filers is 1.86 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $31,467 | +9406.6% | 61,700 | -88.2% | 0.00% | – |
| Q1 2023 | $331 | +34.0% | 524,907 | +37.7% | 0.00% | – |
| Q4 2022 | $247 | -100.0% | 381,233 | -82.4% | 0.00% | -100.0% |
| Q2 2022 | $2,690,000 | +659.9% | 2,169,705 | +300.3% | 0.00% | – |
| Q1 2022 | $354,000 | -82.8% | 542,012 | -71.3% | 0.00% | -100.0% |
| Q4 2021 | $2,061,000 | +15.5% | 1,890,996 | +92.8% | 0.00% | 0.0% |
| Q3 2021 | $1,785,000 | +83.1% | 980,857 | +165.7% | 0.00% | 0.0% |
| Q2 2021 | $975,000 | -53.0% | 369,162 | -55.2% | 0.00% | 0.0% |
| Q4 2020 | $2,075,000 | +11.3% | 823,361 | +11.3% | 0.00% | -50.0% |
| Q3 2020 | $1,864,000 | -57.3% | 739,667 | -44.4% | 0.00% | -66.7% |
| Q2 2020 | $4,362,000 | +5352.5% | 1,329,859 | +3964.9% | 0.01% | – |
| Q1 2020 | $80,000 | -98.8% | 32,716 | -97.7% | 0.00% | -100.0% |
| Q4 2019 | $6,643,000 | +520.8% | 1,407,413 | +462.7% | 0.01% | +300.0% |
| Q3 2019 | $1,070,000 | -47.4% | 250,106 | -28.3% | 0.00% | -33.3% |
| Q2 2019 | $2,035,000 | +5885.3% | 349,041 | +3149.6% | 0.00% | – |
| Q3 2018 | $34,000 | -22.7% | 10,741 | +1.0% | 0.00% | – |
| Q4 2017 | $44,000 | -96.2% | 10,636 | -94.3% | 0.00% | -100.0% |
| Q3 2017 | $1,146,000 | -16.0% | 186,665 | -14.9% | 0.00% | 0.0% |
| Q2 2017 | $1,364,000 | +1504.7% | 219,367 | +1527.2% | 0.00% | – |
| Q1 2017 | $85,000 | -88.3% | 13,481 | -90.1% | 0.00% | -100.0% |
| Q4 2016 | $726,000 | +855.3% | 135,671 | +900.2% | 0.00% | – |
| Q3 2016 | $76,000 | -95.0% | 13,564 | -95.1% | 0.00% | -100.0% |
| Q2 2016 | $1,523,000 | +727.7% | 277,433 | +1153.9% | 0.00% | – |
| Q4 2015 | $184,000 | -86.8% | 22,126 | -85.8% | 0.00% | -100.0% |
| Q3 2015 | $1,399,000 | +2312.1% | 155,279 | +1263.7% | 0.00% | – |
| Q4 2014 | $58,000 | +70.6% | 11,387 | -11.0% | 0.00% | – |
| Q3 2014 | $34,000 | -87.8% | 12,800 | -81.9% | 0.00% | -100.0% |
| Q3 2013 | $279,000 | – | 70,797 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DISCOVERY CAPITAL MANAGEMENT, LLC / CT | 14,642,959 | $25,186,000 | 3.76% |
| MSD Partners, L.P. | 15,151,516 | $26,061,000 | 2.11% |
| MSD Partners, L.P. | 7,575,758 | $13,030,000 | 1.05% |
| MAGNOLIA CAPITAL ADVISORS LLC | 418,569 | $720,000 | 0.61% |
| STEEL GROVE CAPITAL ADVISORS, LLC | 1,080,000 | $1,858,000 | 0.33% |
| EAM Investors, LLC | 454,625 | $782,000 | 0.17% |
| Allred Capital Management, LLC | 158,000 | $271,000 | 0.17% |
| Boxer Capital, LLC | 1,500,000 | $2,580,000 | 0.14% |
| GSA CAPITAL PARTNERS LLP | 608,037 | $1,046,000 | 0.14% |
| CHIRON CAPITAL MANAGEMENT, LLC | 116,860 | $201,000 | 0.14% |